133 related articles for article (PubMed ID: 12871055)
1. Aerosol therapy for malignancy involving the lungs.
Rao RD; Markovic SN; Anderson PM
Curr Cancer Drug Targets; 2003 Aug; 3(4):239-50. PubMed ID: 12871055
[TBL] [Abstract][Full Text] [Related]
2. Aerosol Delivery in the Treatment of Lung Cancer.
Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized chemotherapy.
Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
[TBL] [Abstract][Full Text] [Related]
4. The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.
Densmore CL
Curr Cancer Drug Targets; 2003 Aug; 3(4):275-86. PubMed ID: 12871058
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized Chemotherapy for Osteosarcoma.
Gordon N; Felix K; Daw NC
Adv Exp Med Biol; 2020; 1257():67-73. PubMed ID: 32483731
[TBL] [Abstract][Full Text] [Related]
7. [Inhaled chemotherapy - Part 2: Clinical practice and potential applications].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):378-389. PubMed ID: 29731374
[TBL] [Abstract][Full Text] [Related]
8. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.
Anderson PM; Markovic SN; Sloan JA; Clawson ML; Wylam M; Arndt CA; Smithson WA; Burch P; Gornet M; Rahman E
Clin Cancer Res; 1999 Sep; 5(9):2316-23. PubMed ID: 10499599
[TBL] [Abstract][Full Text] [Related]
9. 9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.
Knight V; Kleinerman ES; Waldrep JC; Giovanella BC; Gilbert BE; Koshkina NV
Ann N Y Acad Sci; 2000; 922():151-63. PubMed ID: 11193890
[TBL] [Abstract][Full Text] [Related]
10. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
11. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
[TBL] [Abstract][Full Text] [Related]
12. Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.
Joshi N; Shirsath N; Singh A; Joshi KS; Banerjee R
Sci Rep; 2014 Nov; 4():7085. PubMed ID: 25403950
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery.
Gautam A; Koshkina N
Curr Cancer Drug Targets; 2003 Aug; 3(4):287-96. PubMed ID: 12871059
[TBL] [Abstract][Full Text] [Related]
14. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapy.
Huland E; Heinzer H; Jörres RA; Loppow D; Huland H
Urologe A; 2004 Sep; 43 Suppl 3():S140-4. PubMed ID: 15179553
[TBL] [Abstract][Full Text] [Related]
16. p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment.
Zou Y; Tornos C; Qiu X; Lia M; Perez-Soler R
Clin Cancer Res; 2007 Aug; 13(16):4900-8. PubMed ID: 17699870
[TBL] [Abstract][Full Text] [Related]
17. Development of inhalational agents for oncologic use.
Sharma S; White D; Imondi AR; Placke ME; Vail DM; Kris MG
J Clin Oncol; 2001 Mar; 19(6):1839-47. PubMed ID: 11251016
[TBL] [Abstract][Full Text] [Related]
18. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Singh M
Pharm Res; 2006 Sep; 23(9):2094-106. PubMed ID: 16902813
[TBL] [Abstract][Full Text] [Related]
19. Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.
Khanna C; Vail DM
Curr Cancer Drug Targets; 2003 Aug; 3(4):265-73. PubMed ID: 12871057
[TBL] [Abstract][Full Text] [Related]
20. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
Hershey AE; Kurzman ID; Forrest LJ; Bohling CA; Stonerook M; Placke ME; Imondi AR; Vail DM
Clin Cancer Res; 1999 Sep; 5(9):2653-9. PubMed ID: 10499645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
